Rokit Healthcare

Rokit Healthcare OCF Margin

The Operating Cash Flow Margin of Rokit Healthcare (376900.KQ) as of Nov 1, 2026 is -65.64 %. In the previous year, Operating Cash Flow Margin was -38.15 % — a change of 72.06% (lower).

OCF Margin

-65.64 %

YoY

72.06%

Last updated:

Operating Cash Flow Margin of Rokit Healthcare is 2025 -65.64 % . Operating Cash Flow Margin of Rokit Healthcare was 2024 -38.15 % . It decreases by 72.06% lower compared to the previous year.

The Rokit Healthcare OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2022
-71.97 KRW
Jan 1, 2023
-31.54 KRW
Jan 1, 2024
-38.15 KRW
Jan 1, 2025
-65.64 KRW
The Rokit Healthcare OCF Margin history
YEAROCF MarginYoY
-65.64 %+72.06%
-38.15 %+20.98%
-31.54 %-56.18%
-71.97 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rokit Healthcare Stock analysis

What does Rokit Healthcare do? Rokit Healthcare Inc develops and sells medical supplies and pharmaceutical products through its AI organ regeneration platform. The company offers three core services: medical 3-dimensional (3D) bioprinting using biocompatible materials, AI automated precision modeling for affected areas, and disposable medical device kits for assembly and disassembly. These services target healthcare providers and medical institutions seeking advanced solutions for organ regeneration and precision medical procedures. The firm also engages in manufacturing, development, sales, wholesale, and retail of medical devices, supporting both domestic and international markets. The medical 3D bioprinting service creates 3D structures with biomaterials, while the AI automated precision modeling service uses artificial intelligence to model affected areas accurately. Disposable medical device kits are sterile and designed for direct assembly and disassembly, catering to hospitals and clinics requiring efficient, sterile medical tools. Rokit Healthcare Inc's business model focuses on delivering integrated AI-driven medical solutions that combine bioprinting, modeling, and disposable device kits to enhance patient care and surgical precision. Rokit Healthcare Inc's primary revenue streams come from the sale of its AI organ regeneration platform services and the associated medical devices. Healthcare providers and medical institutions purchase these services and products to improve treatment outcomes and streamline surgical processes. The company's manufacturing and distribution activities in medical devices further contribute to its revenue, with a strong emphasis on innovation in AI and bioprinting technologies to maintain market competitiveness. Rokit Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rokit Healthcare stock

Operating Cash Flow Margin of Rokit Healthcare is -65.64 % in 2025.

Operating Cash Flow Margin of Rokit Healthcare changed from -38.15 % to -65.64 %, representing a 72.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Rokit Healthcare since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Rokit Healthcare with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Rokit Healthcare

All Key Metrics — Rokit Healthcare